엔코스

비상장계속사업자

ANCORS

홍성훈

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

엔코스

Business Reg. No. 1258184521 · CEO 홍성훈

I.Investment Overview

Target엔코스 (1258184521)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명엔코스
영문명ANCORS
대표자홍성훈
사업자등록번호1258184521
법인등록번호1346110044408
설립일2009.11.19
종업원수286명

V.Workforce

286

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW609.72021552.92022797.820231,525.420241,993.42025
영업이익100M KRW12.920210.5202241.52023190.42024197.22025
순이익100M KRW02021-020226.320230.32024100.62025
Item20252024202320222021
자산총계1,275.6억원876.5억원655.5억원574.6억원571.5억원
부채총계561.9억원564.2억원599.3억원524.7억원496.6억원
자본총계713.7억원312.2억원56.1억원49.8억원74.9억원
매출액1,993.4억원1,525.4억원797.8억원552.9억원609.7억원
영업이익197.2억원190.4억원41.5억원5,220만원12.9억원
순이익100.6억원2,561만원6.3억원-136만원28만원

VII.Financial Ratios

FY2025 basis

9.89%

영업이익률

5.05%

순이익률

7.89%

ROA

14.1%

ROE

78.73%

부채비율

55.95%

자기자본비율

VIII.R&D Activity

Fields 화공 > 섬유제조

Keywords 피부 흡수, 이온성 고분자, 이미지, 하이드로겔

YearProjectsPapersPatents
2016000
2015100

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

엔코스 투심보고서 | Alpha Lenz